Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Fund managers make record rotation out of US stocks - BofA

(Sharecast News) - Fund managers made the sharpest rotation in March out of US stocks and into Europe since records began in 1999, according to the latest fund manager survey from Bank of America. The survey found that 23% of fund managers were 'underweight' US equities, the highest share since mid-2023, with a net 17% having been 'overweight' in February.

As far as European equities are concerned, 39% said they were 'overweight' relative to global markets, up from 12% in February and the biggest 'overweight' since mid-2021.

BofA said global growth was expected to slow, with the US a key drag.

A net 44% of fund managers expected the global economy to weaken over the next 12 months, up from 2% last month, opening up the largest gap to European growth expectations in the last 30 years.

The survey found that 83% of investors expected US growth to slow in the near term, up from 28% last month. However, recession concerns remained low, with 64% seeing a soft landing as the most likely scenario, 19% seeing a no landing and 11% a hard landing.

"A majority now expect the Trump administration to have a negative impact on growth and a positive impact on inflation, effectively anticipated a stagflationary environment (while last month a majority called for a higher-for-longer regime of robust growth and sticky inflation)," Bofa said.

The bank said 69% of fund managers think the theme of US exceptionalism has peaked.

The survey also found that investors had added to their UK exposure, with a newt 4% 'overweight' UK equities in March, versus 18% 'underweight' the month before.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.